Prognostic and clinical significance of contrast enhancement in WHO grade 2 oligodendrogliomas. Zhao X, Zhang Y, Wang Y, Ren X, et al. J Neurooncol 2025;172:481-490.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao X, Zhang Y, Wang Y, Ren X, et al. Prognostic and clinical significance of contrast enhancement in WHO grade 2 oligodendrogliomas. J Neurooncol 2025;172:481-490.
PMID: 39827421